New Leadership at Envision Pharma Group Enhances Innovation Drive
Envision Pharma Group recently announced the appointment of Tom Langan as the new Chief Executive Officer. With a solid background spanning 30 years in the life sciences sector, Tom brings significant expertise in providing technology-driven solutions aimed at enhancing healthcare outcomes.
Before stepping into this prominent role, Tom held the position of interim CEO at Veradigm, a notable healthcare technology firm known for its proficient integration of data, analytics, and software services in advancing healthcare practices. His extensive experience at Veradigm, which lasted over seven years, saw him serving in various capacities, including President and Chief Commercial Officer.
Prior to his tenure at Veradigm, Tom was the CCO and later the CEO of Practice Fusion, a distinguished provider of cloud-based electronic health records. His leadership at Practice Fusion was instrumental in steering the company towards its successful acquisition by Veradigm in 2018. Moreover, he also served as CCO at Symphony Health Solutions, focusing on data analytics and healthcare solutions. Across all his previous roles, Tom has consistently showcased a stellar track record of stimulating product innovation and facilitating business growth.
As he assumes his responsibilities at Envision, Tom is set to propel the company’s global technology service offerings, which already cater to over 400 pharma and biotech clients, including top players in the industry. His leadership is aligned with Envision's ongoing commitment to meet the high demands of an evolving healthcare landscape.
In a statement regarding his new position, Tom Langan expressed pride in leading Envision, highlighting its strong reputation as a top provider of technology-enabled services for healthcare organizations. With a focus on addressing rising healthcare costs and increasing complexity, he aims to drive advanced technology solutions that will benefit life sciences companies throughout their product life cycle.
Alistair Macdonald, the Executive Chairman at Envision Pharma Group, conveyed confidence in Tom's capabilities, noting his client-first approach and proven prowess in delivering technology-driven innovations. Alistair emphasized that Tom’s extensive experience resonates with Envision's mission to mitigate the intricate challenges faced by life sciences organizations today, foreshadowing a collaborative effort to yield favorable results for both clients and personnel.
Envision Pharma Group is recognized as a premier strategic solutions partner in the life sciences sector, established in 2001 and currently working with more than 200 pharma and biotech entities, including all top 20 pharmaceutical companies. The firm provides a spectrum of services underpinned by advanced technology solutions, including artificial intelligence and natural language processing, integrated strategic consulting, evidence-driven scientific communications, market access and data analytics, and omnichannel solutions.
Frequently Asked Questions
What role has Tom Langan taken on at Envision Pharma Group?
Tom Langan has been appointed as the new Chief Executive Officer of Envision Pharma Group, bringing extensive experience in healthcare technology solutions.
What previous positions did Tom Langan hold before joining Envision?
Before joining Envision, Tom was the interim CEO at Veradigm and has also served as CEO of Practice Fusion and CCO at Symphony Health Solutions.
What are the key objectives Tom aims to achieve at Envision?
Tom aims to enhance Envision’s technology service offerings to better meet the needs of pharma and biotech clients in a complex healthcare environment.
How does Envision Pharma Group position itself in the life sciences industry?
Envision Pharma Group is recognized as a leading strategic solutions partner, offering technology-enabled services to top pharmaceutical and biotech companies worldwide.
What type of technology solutions does Envision provide?
Envision offers a wide range of services including AI solutions, strategic consulting, data analytics, and omnichannel solutions focused on enhancing healthcare outcomes.
